Successful Use of Recombinant Activated Factor VII to Reverse Ticagrelor-Induced Bleeding Risk: A Case Report

por Godier, Anne, Dupont, Mélanie, Desilles, Jean-Philippe, Le Guerinel, Caroline, Taylor, Guillaume, Perrin, Mathilde, Martin, Anne-Céline, Gaussem, Pascale
Publicado 2018

BET inhibitor OTX015 targets BRD2 and BRD4 and decreases c-MYC in acute leukemia cells

por Coudé, Marie-Magdelaine, Braun, Thorsten, Berrou, Jeannig, Dupont, Mélanie, Bertrand, Sibyl, Masse, Aline, Raffoux, Emmanuel, Itzykson, Raphaël, Delord, Marc, Riveiro, Maria E., Herait, Patrice, Baruchel, André, Dombret, Hervé, Gardin, Claude
Publicado 2015

Preclinical Evaluation of a Novel Small Molecule Inhibitor of LIM Kinases (LIMK) CEL_Amide in Philadelphia-Chromosome Positive (BCR::ABL+) Acute Lymphoblastic Leukemia (ALL)

por Berrou, Jeannig, Dupont, Mélanie, Djamai, Hanane, Adicéam, Emilie, Parietti, Véronique, Kaci, Anna, Clappier, Emmanuelle, Cayuela, Jean-Michel, Baruchel, André, Paublant, Fabrice, Prudent, Renaud, Ghysdael, Jacques, Gardin, Claude, Dombret, Hervé, Braun, Thorsten
Publicado 2022

Biological Effects of BET Inhibition by OTX015 (MK-8628) and JQ1 in NPM1-Mutated (NPM1c) Acute Myeloid Leukemia (AML)

por Djamai, Hanane, Berrou, Jeannig, Dupont, Mélanie, Coudé, Marie-Magdelaine, Delord, Marc, Clappier, Emmanuelle, Marceau-Renaut, Alice, Kaci, Anna, Raffoux, Emmanuel, Itzykson, Raphaël, Berthier, Caroline, Wu, Hsin-Chieh, Hleihel, Rita, Bazarbachi, Ali, de Thé, Hugues, Baruchel, André, Gardin, Claude, Dombret, Hervé, Braun, Thorsten
Publicado 2021